Deficient Proposed Securities Class Action Settlement Against Drug Maker Denied
SAN DIEGO — A federal judge in California on Dec. 20 denied a motion for preliminary approval of a securities class action settlement between lead plaintiffs and a biopharmaceutical company and...To view the full article, register now.
Already a subscriber? Click here to view full article